Sonic Healthcare Limited operates in the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sonic Healthcare Limited with three other
pharmaceutical manufacturers in Australasia:
Capitol Health Ltd
(2020
sales of 153.79 million Australian Dollars [US$119.12 million]
of which 100%
was Diagnostic Imaging),
Genetic Technologies Limited
(9,864.00 Australian Dollars [US$7,640.56 ]
), and
Integral Diagnostics Ltd
(275.57 million Australian Dollars [US$213.45 million]
of which 100%
was Diagnostic imaging facilities).
Sales Analysis.
Sonic Healthcare Limited reported sales of A$6.83 billion (US$5.29 billion)
for the
fiscal
year ending
June of 2020.
This
represents
an
increase of 11.4%
versus 2019, when the company's sales were A$6.13 billion.
Sales at Sonic Healthcare Limited have increased during each of the previous five years
(and since 2015, sales have increased a total of 63%).
Sales of Laboratory saw an increase
of
13.8% in 2020, from
A$4.99 billion to A$5.67 billion.